Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Increased serum sialic acid is associated with morbidity and mortality in a murine model of dengue disease.

Espinosa DA, Beatty PR, Puerta-Guardo H, Islam MN, Belisle JT, Perera R, Harris E.

J Gen Virol. 2019 Sep 17. doi: 10.1099/jgv.0.001319. [Epub ahead of print]

PMID:
31526452
2.

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes.

Ronacher K, Chegou NN, Kleynhans L, Djoba Siawaya JF, du Plessis N, Loxton AG, Maasdorp E, Tromp G, Kidd M, Stanley K, Kriel M, Menezes A, Gutschmidt A, van der Spuy GD, Warren RM, Dietze R, Okwera A, Thiel B, Belisle JT, Cliff JM, Boom WH, Johnson JL, van Helden PD, Dockrell HM, Walzl G.

Tuberculosis (Edinb). 2019 Aug 12;118:101859. doi: 10.1016/j.tube.2019.101859. [Epub ahead of print]

3.

A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome.

Silva CAM, Graham B, Webb K, Ashton LV, Harton M, Luetkemeyer AF, Bokatzian S, Almubarak R, Mahapatra S, Hovind L, Kendall MA, Havlir D, Belisle JT, De Groote MA.

Int J Infect Dis. 2019 Jul;84:30-38. doi: 10.1016/j.ijid.2019.04.015. Epub 2019 Apr 19.

4.

Mycobacteria and their sweet proteins: An overview of protein glycosylation and lipoglycosylation in M. tuberculosis.

Mehaffy C, Belisle JT, Dobos KM.

Tuberculosis (Edinb). 2019 Mar;115:1-13. doi: 10.1016/j.tube.2019.01.001. Epub 2019 Jan 14. Review.

PMID:
30948163
5.

Correction to "Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy".

Fitzgerald BL, Islam MN, Graham B, Mahapatra S, Webb K, Boom WH, Malherbe ST, Joloba ML, Johnson JL, Winter J, Walzl G, Belisle JT.

ACS Infect Dis. 2019 Jun 14;5(6):1042-1043. doi: 10.1021/acsinfecdis.9b00068. Epub 2019 Mar 13. No abstract available.

6.

Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy.

Fitzgerald BL, Islam MN, Graham B, Mahapatra S, Webb K, Boom WH, Malherbe ST, Joloba ML, Johnson JL, Winter J, Walzl G, Belisle JT.

ACS Infect Dis. 2019 Mar 8;5(3):353-364. doi: 10.1021/acsinfecdis.8b00241. Epub 2019 Jan 10. Erratum in: ACS Infect Dis. 2019 Jun 14;5(6):1042-1043.

7.

Identification of Urine Metabolites as Biomarkers of Early Lyme Disease.

Pegalajar-Jurado A, Fitzgerald BL, Islam MN, Belisle JT, Wormser GP, Waller KS, Ashton LV, Webb KJ, Delorey MJ, Clark RJ, Molins CR.

Sci Rep. 2018 Aug 15;8(1):12204. doi: 10.1038/s41598-018-29713-y.

8.

Evidence of zoonotic leprosy in Pará, Brazilian Amazon, and risks associated with human contact or consumption of armadillos.

da Silva MB, Portela JM, Li W, Jackson M, Gonzalez-Juarrero M, Hidalgo AS, Belisle JT, Bouth RC, Gobbo AR, Barreto JG, Minervino AHH, Cole ST, Avanzi C, Busso P, Frade MAC, Geluk A, Salgado CG, Spencer JS.

PLoS Negl Trop Dis. 2018 Jun 28;12(6):e0006532. doi: 10.1371/journal.pntd.0006532. eCollection 2018 Jun.

9.

Mycobacterium tuberculosis Transfer RNA Induces IL-12p70 via Synergistic Activation of Pattern Recognition Receptors within a Cell Network.

Keegan C, Krutzik S, Schenk M, Scumpia PO, Lu J, Pang YLJ, Russell BS, Lim KS, Shell S, Prestwich E, Su D, Elashoff D, Hershberg RM, Bloom BR, Belisle JT, Fortune S, Dedon PC, Pellegrini M, Modlin RL.

J Immunol. 2018 May 1;200(9):3244-3258. doi: 10.4049/jimmunol.1701733. Epub 2018 Apr 2.

10.

Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis.

Silva CAM, Belisle JT.

Front Immunol. 2018 Feb 2;9:134. doi: 10.3389/fimmu.2018.00134. eCollection 2018. Review.

11.

Dynamic remodeling of lipids coincides with dengue virus replication in the midgut of Aedes aegypti mosquitoes.

Chotiwan N, Andre BG, Sanchez-Vargas I, Islam MN, Grabowski JM, Hopf-Jannasch A, Gough E, Nakayasu E, Blair CD, Belisle JT, Hill CA, Kuhn RJ, Perera R.

PLoS Pathog. 2018 Feb 15;14(2):e1006853. doi: 10.1371/journal.ppat.1006853. eCollection 2018 Feb.

12.

Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI).

Molins CR, Ashton LV, Wormser GP, Andre BG, Hess AM, Delorey MJ, Pilgard MA, Johnson BJ, Webb K, Islam MN, Pegalajar-Jurado A, Molla I, Jewett MW, Belisle JT.

Sci Transl Med. 2017 Aug 16;9(403). pii: eaal2717. doi: 10.1126/scitranslmed.aal2717.

13.

Elucidating the Structure of N1-Acetylisoputreanine: A Novel Polyamine Catabolite in Human Urine.

Fitzgerald BL, Mahapatra S, Farmer DK, McNeil MR, Casero RA Jr, Belisle JT.

ACS Omega. 2017 Jul 31;2(7):3921-3930. doi: 10.1021/acsomega.7b00872. Epub 2017 Jul 25.

14.

Genome-scale analysis of the genes that contribute to Burkholderia pseudomallei biofilm formation identifies a crucial exopolysaccharide biosynthesis gene cluster.

Borlee GI, Plumley BA, Martin KH, Somprasong N, Mangalea MR, Islam MN, Burtnick MN, Brett PJ, Steinmetz I, AuCoin DP, Belisle JT, Crick DC, Schweizer HP, Borlee BR.

PLoS Negl Trop Dis. 2017 Jun 28;11(6):e0005689. doi: 10.1371/journal.pntd.0005689. eCollection 2017 Jun.

15.

Type 1 Reaction in Patients With Leprosy Corresponds to a Decrease in Proresolving Lipid Mediators and an Increase in Proinflammatory Lipid Mediators.

Silva CA, Webb K, Andre BG, Marques MA, Carvalho FM, de Macedo CS, Pinheiro RO, Sarno EN, Pessolani MC, Belisle JT.

J Infect Dis. 2017 Feb 1;215(3):431-439. doi: 10.1093/infdis/jiw541.

PMID:
27932613
16.

Diguanylate cyclase activity of the Mycobacterium leprae T cell antigen ML1419c.

Rotcheewaphan S, Belisle JT, Webb KJ, Kim HJ, Spencer JS, Borlee BR.

Microbiology. 2016 Sep;162(9):1651-1661. doi: 10.1099/mic.0.000339. Epub 2016 Jul 22.

17.

Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae.

Schenk M, Mahapatra S, Le P, Kim HJ, Choi AW, Brennan PJ, Belisle JT, Modlin RL.

Infect Immun. 2016 Aug 19;84(9):2429-38. doi: 10.1128/IAI.00334-16. Print 2016 Sep.

18.

Greazy: Open-Source Software for Automated Phospholipid Tandem Mass Spectrometry Identification.

Kochen MA, Chambers MC, Holman JD, Nesvizhskii AI, Weintraub ST, Belisle JT, Islam MN, Griss J, Tabb DL.

Anal Chem. 2016 Jun 7;88(11):5733-41. doi: 10.1021/acs.analchem.6b00021. Epub 2016 May 24.

19.

Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes.

Voge NV, Perera R, Mahapatra S, Gresh L, Balmaseda A, Loroño-Pino MA, Hopf-Jannasch AS, Belisle JT, Harris E, Blair CD, Beaty BJ.

PLoS Negl Trop Dis. 2016 Feb 25;10(2):e0004449. doi: 10.1371/journal.pntd.0004449. eCollection 2016 Feb.

20.

The Essential Role of Cholesterol Metabolism in the Intracellular Survival of Mycobacterium leprae Is Not Coupled to Central Carbon Metabolism and Energy Production.

Marques MA, Berrêdo-Pinho M, Rosa TL, Pujari V, Lemes RM, Lery LM, Silva CA, Guimarães AC, Atella GC, Wheat WH, Brennan PJ, Crick DC, Belisle JT, Pessolani MC.

J Bacteriol. 2015 Dec;197(23):3698-707. doi: 10.1128/JB.00625-15. Epub 2015 Sep 21.

21.

Short communication: Proteomic characterization of tuberculin purified protein derivative from Mycobacterium bovis.

Cho YS, Jang YB, Lee SE, Cho JY, Ahn JM, Hwang I, Heo E, Nam HM, Cho D, Her M, Jean YH, Jung SC, Kim JM, Lee HS, Lee K, Belisle JT.

Res Vet Sci. 2015 Aug;101:117-9. doi: 10.1016/j.rvsc.2015.06.003. Epub 2015 Jun 20.

PMID:
26267100
22.

Mycobacterial Lipidomics.

Layre E, Al-Mubarak R, Belisle JT, Branch Moody D.

Microbiol Spectr. 2014 Jun;2(3). doi: 10.1128/microbiolspec.MGM2-0033-2013. Review.

PMID:
26103971
23.

Development of a metabolic biosignature for detection of early Lyme disease.

Molins CR, Ashton LV, Wormser GP, Hess AM, Delorey MJ, Mahapatra S, Schriefer ME, Belisle JT.

Clin Infect Dis. 2015 Jun 15;60(12):1767-75. doi: 10.1093/cid/civ185. Epub 2015 Mar 11.

24.

Francisella tularensis LVS surface and membrane proteins as targets of effective post-exposure immunization for tularemia.

Chandler JC, Sutherland MD, Harton MR, Molins CR, Anderson RV, Heaslip DG, Bosio CM, Belisle JT.

J Proteome Res. 2015 Feb 6;14(2):664-75. doi: 10.1021/pr500628k. Epub 2014 Dec 29.

25.

Carbohydrate-dependent binding of langerin to SodC, a cell wall glycoprotein of Mycobacterium leprae.

Kim HJ, Brennan PJ, Heaslip D, Udey MC, Modlin RL, Belisle JT.

J Bacteriol. 2015 Feb;197(3):615-25. doi: 10.1128/JB.02080-14. Epub 2014 Nov 24.

26.

Isolation and purification of Mycobacterium tuberculosis from H37Rv infected guinea pig lungs.

Shi L, Ryan GJ, Bhamidi S, Troudt J, Amin A, Izzo A, Lenaerts AJ, McNeil MR, Belisle JT, Crick DC, Chatterjee D.

Tuberculosis (Edinb). 2014 Sep;94(5):525-30. doi: 10.1016/j.tube.2014.05.003. Epub 2014 Jun 30.

PMID:
25037320
27.

Virulence difference between the prototypic Schu S4 strain (A1a) and Francisella tularensis A1a, A1b, A2 and type B strains in a murine model of infection.

Molins CR, Delorey MJ, Yockey BM, Young JW, Belisle JT, Schriefer ME, Petersen JM.

BMC Infect Dis. 2014 Feb 6;14:67. doi: 10.1186/1471-2334-14-67.

28.

A metabolic biosignature of early response to anti-tuberculosis treatment.

Mahapatra S, Hess AM, Johnson JL, Eisenach KD, DeGroote MA, Gitta P, Joloba ML, Kaplan G, Walzl G, Boom WH, Belisle JT.

BMC Infect Dis. 2014 Jan 31;14:53. doi: 10.1186/1471-2334-14-53.

29.

Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.

Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW.

Infect Immun. 2013 Sep;81(9):3099-105. doi: 10.1128/IAI.00203-13. Epub 2013 Jun 17.

30.

Use of temperature for standardizing the progression of Francisella tularensis in mice.

Molins CR, Delorey MJ, Young JW, Yockey BM, Belisle JT, Schriefer ME, Petersen JM.

PLoS One. 2012;7(9):e45310. doi: 10.1371/journal.pone.0045310. Epub 2012 Sep 24.

31.

Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia.

Sutherland MD, Goodyear AW, Troyer RM, Chandler JC, Dow SW, Belisle JT.

Vaccine. 2012 Jul 13;30(33):4977-82. doi: 10.1016/j.vaccine.2012.05.037. Epub 2012 May 28.

32.

Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells.

Torrelles JB, Sieling PA, Zhang N, Keen MA, McNeil MR, Belisle JT, Modlin RL, Brennan PJ, Chatterjee D.

Glycobiology. 2012 Aug;22(8):1118-27. doi: 10.1093/glycob/cws078. Epub 2012 Apr 25.

33.

Deciphering the proteome of the in vivo diagnostic reagent "purified protein derivative" from Mycobacterium tuberculosis.

Cho YS, Dobos KM, Prenni J, Yang H, Hess A, Rosenkrands I, Andersen P, Ryoo SW, Bai GH, Brennan MJ, Izzo A, Bielefeldt-Ohmann H, Belisle JT.

Proteomics. 2012 Apr;12(7):979-91. doi: 10.1002/pmic.201100544.

34.

Stable extracellular RNA fragments of Mycobacterium tuberculosis induce early apoptosis in human monocytes via a caspase-8 dependent mechanism.

Obregón-Henao A, Duque-Correa MA, Rojas M, García LF, Brennan PJ, Ortiz BL, Belisle JT.

PLoS One. 2012;7(1):e29970. doi: 10.1371/journal.pone.0029970. Epub 2012 Jan 9.

35.

A bioanalytical method to determine the cell wall composition of Mycobacterium tuberculosis grown in vivo.

Bhamidi S, Shi L, Chatterjee D, Belisle JT, Crick DC, McNeil MR.

Anal Biochem. 2012 Feb 1;421(1):240-9. doi: 10.1016/j.ab.2011.10.046. Epub 2011 Nov 4.

PMID:
22107887
36.

A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct.

Mahapatra S, Woolhiser LK, Lenaerts AJ, Johnson JL, Eisenach KD, Joloba ML, Boom WH, Belisle JT.

Antimicrob Agents Chemother. 2012 Jan;56(1):28-35. doi: 10.1128/AAC.05486-11. Epub 2011 Oct 28.

37.

CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.

Nahid P, Saukkonen J, Mac Kenzie WR, Johnson JL, Phillips PP, Andersen J, Bliven-Sizemore E, Belisle JT, Boom WH, Luetkemeyer A, Campbell TB, Eisenach KD, Hafner R, Lennox JL, Makhene M, Swindells S, Villarino ME, Weiner M, Benson C, Burman W; National Institutes of Health; Centers for Disease Control and Prevention.

Am J Respir Crit Care Med. 2011 Oct 15;184(8):972-9. doi: 10.1164/rccm.201105-0827WS.

38.

Detailed structural and quantitative analysis reveals the spatial organization of the cell walls of in vivo grown Mycobacterium leprae and in vitro grown Mycobacterium tuberculosis.

Bhamidi S, Scherman MS, Jones V, Crick DC, Belisle JT, Brennan PJ, McNeil MR.

J Biol Chem. 2011 Jul 1;286(26):23168-77. doi: 10.1074/jbc.M110.210534. Epub 2011 May 9.

39.

Differential chitinase activity and production within Francisella species, subspecies, and subpopulations.

Chandler JC, Molins CR, Petersen JM, Belisle JT.

J Bacteriol. 2011 Jul;193(13):3265-75. doi: 10.1128/JB.00093-11. Epub 2011 Apr 29.

40.

Lipidomic analyses of Mycobacterium tuberculosis based on accurate mass measurements and the novel "Mtb LipidDB".

Sartain MJ, Dick DL, Rithner CD, Crick DC, Belisle JT.

J Lipid Res. 2011 May;52(5):861-72. doi: 10.1194/jlr.M010363. Epub 2011 Feb 1.

41.

Analysis of lipids from crude lung tissue extracts by desorption electrospray ionization mass spectrometry and pattern recognition.

Basile F, Sibray T, Belisle JT, Bowen RA.

Anal Biochem. 2011 Jan 15;408(2):289-96. doi: 10.1016/j.ab.2010.09.017. Epub 2010 Sep 22.

42.

Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens.

Ireland R, Olivares-Zavaleta N, Warawa JM, Gherardini FC, Jarrett C, Hinnebusch BJ, Belisle JT, Fairman J, Bosio CM.

PLoS Pathog. 2010 May 27;6(5):e1000921. doi: 10.1371/journal.ppat.1000921.

43.

TLR2 looks at lipoproteins.

Schenk M, Belisle JT, Modlin RL.

Immunity. 2009 Dec 18;31(6):847-9. doi: 10.1016/j.immuni.2009.11.008.

44.

Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients.

Deenadayalan A, Heaslip D, Rajendiran AA, Velayudham BV, Frederick S, Yang HL, Dobos K, Belisle JT, Raja A.

Mol Cell Proteomics. 2010 Mar;9(3):538-49. doi: 10.1074/mcp.M900299-MCP200. Epub 2009 Dec 22.

45.

IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia.

del Corral H, París SC, Marín ND, Marín DM, López L, Henao HM, Martínez T, Villa L, Barrera LF, Ortiz BL, Ramírez ME, Montes CJ, Oquendo MC, Arango LM, Riaño F, Aguirre C, Bustamante A, Belisle JT, Dobos K, Mejía GI, Giraldo MR, Brennan PJ, Robledo J, Arbeláez MP, Rojas CA, García LF.

PLoS One. 2009 Dec 14;4(12):e8257. doi: 10.1371/journal.pone.0008257.

46.

Peptides of a novel Mycobacterium tuberculosis-specific cell wall protein for immunodiagnosis of tuberculosis.

Singh KK, Sharma N, Vargas D, Liu Z, Belisle JT, Potharaju V, Wanchu A, Behera D, Laal S.

J Infect Dis. 2009 Aug 15;200(4):571-81. doi: 10.1086/603539.

47.

Isolation of mycobacterium species genomic DNA.

Belisle JT, Mahaffey SB, Hill PJ.

Methods Mol Biol. 2009;465:1-12. doi: 10.1007/978-1-59745-207-6_1.

PMID:
20560080
48.

Morphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosis.

Slayden RA, Belisle JT.

J Antimicrob Chemother. 2009 Mar;63(3):451-7. doi: 10.1093/jac/dkn507. Epub 2008 Dec 24.

49.

N-Terminal clustering of the O-glycosylation sites in the Mycobacterium tuberculosis lipoprotein SodC.

Sartain MJ, Belisle JT.

Glycobiology. 2009 Jan;19(1):38-51. doi: 10.1093/glycob/cwn102. Epub 2008 Oct 8.

50.

Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan.

Torrelles JB, Knaup R, Kolareth A, Slepushkina T, Kaufman TM, Kang P, Hill PJ, Brennan PJ, Chatterjee D, Belisle JT, Musser JM, Schlesinger LS.

J Biol Chem. 2008 Nov 14;283(46):31417-28. doi: 10.1074/jbc.M806350200. Epub 2008 Sep 10.

Supplemental Content

Loading ...
Support Center